(Q40464366)

20 September 2017

A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. (English)

1 reference

20 September 2017

0 references

1 reference

Leon A Adams

1

1 reference

20 September 2017

Claudia O Zein

series ordinal

2

1 reference

20 September 2017

Paul Angulo

series ordinal

3

1 reference

20 September 2017

Keith D Lindor

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

The American Journal of Gastroenterology

20 September 2017

1 reference

20 September 2017

99

1 reference

20 September 2017

12

1 reference

20 September 2017

2365-2368

1 reference

Cytokines in alcoholic and nonalcoholic steatohepatitis

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40064.X

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40064.X

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40064.X

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40064.X

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40064.X

Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40064.X

10.1111/J.1572-0241.2004.40064.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference